http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008127169-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008127169-A
titleOfInvention TRANSDERMAL SYSTEM WITH ACE-ENZYME DICARBONIC ACID INHIBITOR SALTS AND WITH THE CONTROL OF THEIR RELEASE MATRIX
abstract 1. Transdermal therapeutic system containing at least one salt of a dicarboxylic acid inhibitor of an ACE enzyme with at least one organic amine in a molar ratio in the salt between a dicarboxylic acid inhibitor of an ACE enzyme and amine 1: <2. ! 2. The transdermal therapeutic system according to claim 1, containing a salt with monoamine as an organic amine. ! 3. The transdermal therapeutic system according to claim 1, containing a salt with a primary, secondary or tertiary amine as an organic amine. ! 4. The transdermal therapeutic system according to claim 1, containing an amine salt of a dicarboxylic acid inhibitor of an ACE enzyme selected from the group of dicarboxylic acids, including imidapril, fosinopril, moexipril, perindopril, spirapril, benazepril, cilazapril, lisinopril, hinapril, ena delapril, ramipril and trandolapril. ! 5. The transdermal therapeutic system according to claim 1, containing a salt of at least one dicarboxylic acid inhibitor of an ACE enzyme selected from the group of dicarboxylic acids, including imidapril, fosinopril, moexipril, perindopril, spirapril, benazepril, cilazapril, lisinopril, quinapril, enal , delapril, ramipril and trandolapril, with a primary, secondary or tertiary amine as an organic amine. ! 6. The transdermal therapeutic system according to claim 1, consisting of an outer layer not permeable to the active substance, one or more self-adhesive matrix layers containing the active substance, and a removable protective layer. ! 7. The transdermal therapeutic system according to claim 1, containing a salt of a dicarboxylic acid ACE enzyme inhibitor is selected
priorityDate 2005-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456653168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414028195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410389413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3025823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413994091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414887638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420233562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419769253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426081315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408961158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9601226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410534197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38988487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413958311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426267151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426147843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 103.